Oculis (OCS) News
NASDAQ: OCSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.34-0.32 (-3.70%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
OCS news summary
We found 1 recent headline mentioning Oculis (OCS): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. For price context, OCS is down 3.70% at $8.34. The most recent story, "Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities", was published by GlobeNewswire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology